Loss of FRA7G heterozygosity is seen in many human malignancies, and some studies suggest that genetic and epigenetic alterations of one or more tumor suppressor genes in the FRA7G region, potentially including TES, are involved in multiple malignancies [20, 21]. The gene discussed is TES; the disease is neoplasm.